RETA
Reata Pharmaceuticals Inc
Price:  
172.36 
USD
Volume:  
1,986,840.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RETA WACC - Weighted Average Cost of Capital

The WACC of Reata Pharmaceuticals Inc (RETA) is 8.1%.

The Cost of Equity of Reata Pharmaceuticals Inc (RETA) is 9.15%.
The Cost of Debt of Reata Pharmaceuticals Inc (RETA) is 7.00%.

Range Selected
Cost of equity 7.40% - 10.90% 9.15%
Tax rate -% - 0.10% 0.05%
Cost of debt 7.00% - 7.00% 7.00%
WACC 7.2% - 9.0% 8.1%
WACC

RETA WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.77 1.09
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.40% 10.90%
Tax rate -% 0.10%
Debt/Equity ratio 1 1
Cost of debt 7.00% 7.00%
After-tax WACC 7.2% 9.0%
Selected WACC 8.1%